Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(5-[[(1H-indol-3-ylacetyl)oxy]methyl]-2,3,4,7-tetrahydro-1H-azepin-3-yl)methyl 4-aminobenzoate | - |
Plasmodium falciparum | |
(5-[[(1H-indol-3-ylacetyl)oxy]methyl]-2,3,4,7-tetrahydro-1H-azepin-3-yl)methyl 4-nitrobenzoate | - |
Plasmodium falciparum | |
(5-[[(phenylcarbonyl)oxy]methyl]-2,3,4,7-tetrahydro-1H-azepin-3-yl)methyl 4-aminobenzoate | - |
Plasmodium falciparum | |
(5-[[(phenylcarbonyl)oxy]methyl]-2,3,4,7-tetrahydro-1H-azepin-3-yl)methyl 4-nitrobenzoate | - |
Plasmodium falciparum | |
(6-[[(phenylcarbonyl)oxy]methyl]-2,5,6,7-tetrahydro-1H-azepin-4-yl)methyl 4-aminobenzoate | - |
Plasmodium falciparum | |
(6-[[(phenylcarbonyl)oxy]methyl]-2,5,6,7-tetrahydro-1H-azepin-4-yl)methyl 4-nitrobenzoate | - |
Plasmodium falciparum | |
2,3,4,7-tetrahydro-1H-azepine-3,5-diyldimethanediyl bis(4-aminobenzoate) | - |
Plasmodium falciparum | |
2,3,4,7-tetrahydro-1H-azepine-3,5-diyldimethanediyl bis(4-nitrobenzoate) | - |
Plasmodium falciparum | |
2,3,4,7-tetrahydro-1H-azepine-3,5-diyldimethanediyl dibenzoate | - |
Plasmodium falciparum | |
additional information | computer-aided design and synthesis of nonpeptidic plasmepsin II and IV inhibitors | Plasmodium falciparum | |
[5-([[(4-bromophenyl)carbonyl]oxy]methyl)-2,3,4,7-tetrahydro-1H-azepin-3-yl]methyl 4-aminobenzoate | - |
Plasmodium falciparum | |
[6-([[(4-aminophenyl)carbonyl]oxy]methyl)-2,5,6,7-tetrahydro-1H-azepin-4-yl]methyl naphthalene-1-carboxylate | - |
Plasmodium falciparum | |
[6-([[(4-nitrophenyl)carbonyl]oxy]methyl)-2,5,6,7-tetrahydro-1H-azepin-4-yl]methyl 4-bromobenzoate | - |
Plasmodium falciparum | |
[6-([[(4-nitrophenyl)carbonyl]oxy]methyl)-2,5,6,7-tetrahydro-1H-azepin-4-yl]methyl naphthalene-1-carboxylate | - |
Plasmodium falciparum |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
vacuole | - |
Plasmodium falciparum | 5773 | - |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Plasmodium falciparum | - |
- |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
Hemoglobin + H2O | the enzyme is involved in host hemoglobin degradation | Plasmodium falciparum | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
Plm IV | - |
Plasmodium falciparum |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.0015 | - |
[6-([[(4-aminophenyl)carbonyl]oxy]methyl)-2,5,6,7-tetrahydro-1H-azepin-4-yl]methyl naphthalene-1-carboxylate | plasmepsin IV | Plasmodium falciparum | |
0.0032 | - |
2,3,4,7-tetrahydro-1H-azepine-3,5-diyldimethanediyl bis(4-aminobenzoate) | plasmepsin IV | Plasmodium falciparum | |
0.0039 | - |
[6-([[(4-nitrophenyl)carbonyl]oxy]methyl)-2,5,6,7-tetrahydro-1H-azepin-4-yl]methyl naphthalene-1-carboxylate | plasmepsin IV | Plasmodium falciparum | |
0.0057 | - |
[5-([[(4-bromophenyl)carbonyl]oxy]methyl)-2,3,4,7-tetrahydro-1H-azepin-3-yl]methyl 4-aminobenzoate | plasmepsin IV | Plasmodium falciparum | |
0.0072 | - |
(5-[[(phenylcarbonyl)oxy]methyl]-2,3,4,7-tetrahydro-1H-azepin-3-yl)methyl 4-aminobenzoate | plasmepsin IV | Plasmodium falciparum | |
0.0099 | - |
(6-[[(phenylcarbonyl)oxy]methyl]-2,5,6,7-tetrahydro-1H-azepin-4-yl)methyl 4-aminobenzoate | plasmepsin IV | Plasmodium falciparum | |
0.0159 | - |
(5-[[(1H-indol-3-ylacetyl)oxy]methyl]-2,3,4,7-tetrahydro-1H-azepin-3-yl)methyl 4-aminobenzoate | plasmepsin IV | Plasmodium falciparum | |
0.0221 | - |
2,3,4,7-tetrahydro-1H-azepine-3,5-diyldimethanediyl bis(4-nitrobenzoate) | plasmepsin IV | Plasmodium falciparum | |
0.029 | - |
(6-[[(phenylcarbonyl)oxy]methyl]-2,5,6,7-tetrahydro-1H-azepin-4-yl)methyl 4-nitrobenzoate | plasmepsin IV | Plasmodium falciparum | |
0.0386 | - |
(5-[[(phenylcarbonyl)oxy]methyl]-2,3,4,7-tetrahydro-1H-azepin-3-yl)methyl 4-nitrobenzoate | plasmepsin IV | Plasmodium falciparum | |
0.0434 | - |
(5-[[(1H-indol-3-ylacetyl)oxy]methyl]-2,3,4,7-tetrahydro-1H-azepin-3-yl)methyl 4-nitrobenzoate | plasmepsin IV | Plasmodium falciparum | |
0.0688 | - |
[6-([[(4-nitrophenyl)carbonyl]oxy]methyl)-2,5,6,7-tetrahydro-1H-azepin-4-yl]methyl 4-bromobenzoate | plasmepsin IV | Plasmodium falciparum | |
0.211 | - |
2,3,4,7-tetrahydro-1H-azepine-3,5-diyldimethanediyl dibenzoate | plasmepsin IV | Plasmodium falciparum |